The breast cancer recurrence score test is a genomic test that extracts breast cancer tissue during surgery to check the activity of certain genes related to breast cancer, which is very helpful for the treatment of breast cancer. In addition, the breast cancer recurrence score test can also estimate the risk of early breast cancer.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Recurrence Score Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Recurrence Score Test. This report contains market size and forecasts of Breast Cancer Recurrence Score Test in global, including the following market information:
Global Breast Cancer Recurrence Score Test Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Breast Cancer Recurrence Score Test market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stage I Invasive Breast Cancer Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Breast Cancer Recurrence Score Test include Roche Diagnostics, Braster, Bremed, Forward Science Technologies, Guided Therapeutics, Varian Medical Systems, LED Dental, PWB Health and Zilico Medical Diagnostics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Breast Cancer Recurrence Score Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Breast Cancer Recurrence Score Test Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Recurrence Score Test Market Segment Percentages, by Type, 2022 (%)
Stage I Invasive Breast Cancer
Stage II Invasive Breast Cancer
Estrogen Receptor-positive Cancer
Lymph Node-negative Breast Cancer
Global Breast Cancer Recurrence Score Test Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Breast Cancer Recurrence Score Test Market Segment Percentages, by Application, 2022 (%)
Hospitals
Speciality Cancer Centers
Advanced Diagnostic Centers
Others
Global Breast Cancer Recurrence Score Test Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Breast Cancer Recurrence Score Test Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Breast Cancer Recurrence Score Test revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Breast Cancer Recurrence Score Test revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Braster
Bremed
Forward Science Technologies
Guided Therapeutics
Varian Medical Systems
LED Dental
PWB Health
Zilico Medical Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Breast Cancer Recurrence Score Test, market overview.
Chapter 2: Global Breast Cancer Recurrence Score Test market size in revenue.
Chapter 3: Detailed analysis of Breast Cancer Recurrence Score Test company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Recurrence Score Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Recurrence Score Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Breast Cancer Recurrence Score Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Breast Cancer Recurrence Score Test Overall Market Size
2.1 Global Breast Cancer Recurrence Score Test Market Size: 2022 VS 2029
2.2 Global Breast Cancer Recurrence Score Test Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Breast Cancer Recurrence Score Test Players in Global Market
3.2 Top Global Breast Cancer Recurrence Score Test Companies Ranked by Revenue
3.3 Global Breast Cancer Recurrence Score Test Revenue by Companies
3.4 Top 3 and Top 5 Breast Cancer Recurrence Score Test Companies in Global Market, by Revenue in 2022
3.5 Global Companies Breast Cancer Recurrence Score Test Product Type
3.6 Tier 1, Tier 2 and Tier 3 Breast Cancer Recurrence Score Test Players in Global Market
3.6.1 List of Global Tier 1 Breast Cancer Recurrence Score Test Companies
3.6.2 List of Global Tier 2 and Tier 3 Breast Cancer Recurrence Score Test Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Breast Cancer Recurrence Score Test Market Size Markets, 2022 & 2029
4.1.2 Stage I Invasive Breast Cancer
4.1.3 Stage II Invasive Breast Cancer
4.1.4 Estrogen Receptor-positive Cancer
4.1.5 Lymph Node-negative Breast Cancer
4.2 By Type - Global Breast Cancer Recurrence Score Test Revenue & Forecasts
4.2.1 By Type - Global Breast Cancer Recurrence Score Test Revenue, 2018-2023
4.2.2 By Type - Global Breast Cancer Recurrence Score Test Revenue, 2024-2029
4.2.3 By Type - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Breast Cancer Recurrence Score Test Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Speciality Cancer Centers
5.1.4 Advanced Diagnostic Centers
5.1.5 Others
5.2 By Application - Global Breast Cancer Recurrence Score Test Revenue & Forecasts
5.2.1 By Application - Global Breast Cancer Recurrence Score Test Revenue, 2018-2023
5.2.2 By Application - Global Breast Cancer Recurrence Score Test Revenue, 2024-2029
5.2.3 By Application - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Breast Cancer Recurrence Score Test Market Size, 2022 & 2029
6.2 By Region - Global Breast Cancer Recurrence Score Test Revenue & Forecasts
6.2.1 By Region - Global Breast Cancer Recurrence Score Test Revenue, 2018-2023
6.2.2 By Region - Global Breast Cancer Recurrence Score Test Revenue, 2024-2029
6.2.3 By Region - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Breast Cancer Recurrence Score Test Revenue, 2018-2029
6.3.2 US Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.3.3 Canada Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.3.4 Mexico Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Breast Cancer Recurrence Score Test Revenue, 2018-2029
6.4.2 Germany Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4.3 France Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4.4 U.K. Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4.5 Italy Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4.6 Russia Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4.7 Nordic Countries Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.4.8 Benelux Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Breast Cancer Recurrence Score Test Revenue, 2018-2029
6.5.2 China Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.5.3 Japan Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.5.4 South Korea Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.5.5 Southeast Asia Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.5.6 India Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Breast Cancer Recurrence Score Test Revenue, 2018-2029
6.6.2 Brazil Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.6.3 Argentina Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Breast Cancer Recurrence Score Test Revenue, 2018-2029
6.7.2 Turkey Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.7.3 Israel Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.7.4 Saudi Arabia Breast Cancer Recurrence Score Test Market Size, 2018-2029
6.7.5 UAE Breast Cancer Recurrence Score Test Market Size, 2018-2029
7 Breast Cancer Recurrence Score Test Companies Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Breast Cancer Recurrence Score Test Major Product Offerings
7.1.4 Roche Diagnostics Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 Braster
7.2.1 Braster Company Summary
7.2.2 Braster Business Overview
7.2.3 Braster Breast Cancer Recurrence Score Test Major Product Offerings
7.2.4 Braster Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.2.5 Braster Key News & Latest Developments
7.3 Bremed
7.3.1 Bremed Company Summary
7.3.2 Bremed Business Overview
7.3.3 Bremed Breast Cancer Recurrence Score Test Major Product Offerings
7.3.4 Bremed Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.3.5 Bremed Key News & Latest Developments
7.4 Forward Science Technologies
7.4.1 Forward Science Technologies Company Summary
7.4.2 Forward Science Technologies Business Overview
7.4.3 Forward Science Technologies Breast Cancer Recurrence Score Test Major Product Offerings
7.4.4 Forward Science Technologies Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.4.5 Forward Science Technologies Key News & Latest Developments
7.5 Guided Therapeutics
7.5.1 Guided Therapeutics Company Summary
7.5.2 Guided Therapeutics Business Overview
7.5.3 Guided Therapeutics Breast Cancer Recurrence Score Test Major Product Offerings
7.5.4 Guided Therapeutics Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.5.5 Guided Therapeutics Key News & Latest Developments
7.6 Varian Medical Systems
7.6.1 Varian Medical Systems Company Summary
7.6.2 Varian Medical Systems Business Overview
7.6.3 Varian Medical Systems Breast Cancer Recurrence Score Test Major Product Offerings
7.6.4 Varian Medical Systems Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.6.5 Varian Medical Systems Key News & Latest Developments
7.7 LED Dental
7.7.1 LED Dental Company Summary
7.7.2 LED Dental Business Overview
7.7.3 LED Dental Breast Cancer Recurrence Score Test Major Product Offerings
7.7.4 LED Dental Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.7.5 LED Dental Key News & Latest Developments
7.8 PWB Health
7.8.1 PWB Health Company Summary
7.8.2 PWB Health Business Overview
7.8.3 PWB Health Breast Cancer Recurrence Score Test Major Product Offerings
7.8.4 PWB Health Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.8.5 PWB Health Key News & Latest Developments
7.9 Zilico Medical Diagnostics
7.9.1 Zilico Medical Diagnostics Company Summary
7.9.2 Zilico Medical Diagnostics Business Overview
7.9.3 Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Major Product Offerings
7.9.4 Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Revenue in Global Market (2018-2023)
7.9.5 Zilico Medical Diagnostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Breast Cancer Recurrence Score Test Market Opportunities & Trends in Global Market
Table 2. Breast Cancer Recurrence Score Test Market Drivers in Global Market
Table 3. Breast Cancer Recurrence Score Test Market Restraints in Global Market
Table 4. Key Players of Breast Cancer Recurrence Score Test in Global Market
Table 5. Top Breast Cancer Recurrence Score Test Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Breast Cancer Recurrence Score Test Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Breast Cancer Recurrence Score Test Revenue Share by Companies, 2018-2023
Table 8. Global Companies Breast Cancer Recurrence Score Test Product Type
Table 9. List of Global Tier 1 Breast Cancer Recurrence Score Test Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Breast Cancer Recurrence Score Test Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Breast Cancer Recurrence Score Test Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Breast Cancer Recurrence Score Test Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Breast Cancer Recurrence Score Test Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Breast Cancer Recurrence Score Test Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Breast Cancer Recurrence Score Test Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Breast Cancer Recurrence Score Test Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2024-2029
Table 30. Roche Diagnostics Company Summary
Table 31. Roche Diagnostics Breast Cancer Recurrence Score Test Product Offerings
Table 32. Roche Diagnostics Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Diagnostics Key News & Latest Developments
Table 34. Braster Company Summary
Table 35. Braster Breast Cancer Recurrence Score Test Product Offerings
Table 36. Braster Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 37. Braster Key News & Latest Developments
Table 38. Bremed Company Summary
Table 39. Bremed Breast Cancer Recurrence Score Test Product Offerings
Table 40. Bremed Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 41. Bremed Key News & Latest Developments
Table 42. Forward Science Technologies Company Summary
Table 43. Forward Science Technologies Breast Cancer Recurrence Score Test Product Offerings
Table 44. Forward Science Technologies Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 45. Forward Science Technologies Key News & Latest Developments
Table 46. Guided Therapeutics Company Summary
Table 47. Guided Therapeutics Breast Cancer Recurrence Score Test Product Offerings
Table 48. Guided Therapeutics Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 49. Guided Therapeutics Key News & Latest Developments
Table 50. Varian Medical Systems Company Summary
Table 51. Varian Medical Systems Breast Cancer Recurrence Score Test Product Offerings
Table 52. Varian Medical Systems Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 53. Varian Medical Systems Key News & Latest Developments
Table 54. LED Dental Company Summary
Table 55. LED Dental Breast Cancer Recurrence Score Test Product Offerings
Table 56. LED Dental Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 57. LED Dental Key News & Latest Developments
Table 58. PWB Health Company Summary
Table 59. PWB Health Breast Cancer Recurrence Score Test Product Offerings
Table 60. PWB Health Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 61. PWB Health Key News & Latest Developments
Table 62. Zilico Medical Diagnostics Company Summary
Table 63. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Product Offerings
Table 64. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Revenue (US$, Mn) & (2018-2023)
Table 65. Zilico Medical Diagnostics Key News & Latest Developments
List of Figures
Figure 1. Breast Cancer Recurrence Score Test Segment by Type in 2022
Figure 2. Breast Cancer Recurrence Score Test Segment by Application in 2022
Figure 3. Global Breast Cancer Recurrence Score Test Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Breast Cancer Recurrence Score Test Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Breast Cancer Recurrence Score Test Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Breast Cancer Recurrence Score Test Revenue in 2022
Figure 8. By Type - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 9. By Application - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 10. By Type - Global Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 12. By Application - Global Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 14. By Region - Global Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 15. By Country - North America Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 16. US Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 20. Germany Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 21. France Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 28. China Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 32. India Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 34. Brazil Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Breast Cancer Recurrence Score Test Revenue Market Share, 2018-2029
Figure 37. Turkey Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Breast Cancer Recurrence Score Test Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Diagnostics Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Braster Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bremed Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Forward Science Technologies Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Guided Therapeutics Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Varian Medical Systems Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LED Dental Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. PWB Health Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Zilico Medical Diagnostics Breast Cancer Recurrence Score Test Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
